MiNK Therapeutics Ownership | Who Owns MiNK Therapeutics?

Overview ForecastFinancials Chart Transcripts

MiNK Therapeutics Ownership Summary

MiNK Therapeutics is owned by 4.07% institutional investors, 59.23% insiders, and 36.70% retail investors. Geode capital management is the largest institutional shareholder, holding 0.41% of INKT shares. DNB Fund Disrpt Opps A EUR Acc is the top mutual fund, with 1.11% of its assets in MiNK Therapeutics shares.

INKT Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	MiNK Therapeutics	4.07%	59.23%	36.70%
Sector	Healthcare Stocks	244.59%	12.11%	-156.70%
Industry	Biotech Stocks	379.61%	11.70%	-291.31%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Geode capital management	17.34K	0.41%	$182.67K
Longbow finance sa	16.67K	0.39%	$175.50K
Ubs group	15.20K	0.36%	$160.08K
Blackrock	87.20K	0.25%	$82.77K
Vanguard fiduciary trust	8.29K	0.19%	$87.26K
Blackrock funding, inc. /de	6.20K	0.15%	$65.32K
State street	25.52K	0.06%	$17.78K
Goldman sachs group	17.56K	0.05%	$16.67K
Steward partners investment advisory	2.00K	0.05%	$21.06K
Millennium management	13.12K	0.04%	$12.45K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Longbow finance sa	16.67K	0.03%	$175.50K
Covestor	119.00	0.00%	$1.00K
Game plan financial advisors	16.00	0.00%	$168.00
Steward partners investment advisory	2.00K	0.00%	$21.06K
Horizon financial services	-	-	-
Tower research capital llc (trc)	156.00	-	$1.64K
Drw securities	-	-	-
Barclays	-	-	-
Blackrock	87.20K	-	$82.77K
Two sigma securities	-	-	-

Top Buyers

Holder	Shares	% Assets	Change
Blackrock	87.20K	-	11.05K
Vanguard fiduciary trust	8.29K	-	8.29K
Ubs group	15.20K	-	5.65K
Geode capital management	17.34K	-	3.10K
Steward partners investment advisory	2.00K	0.00%	2.00K

Top Sellers

Holder	Shares	% Assets	Change
Vanguard group	-	-	-234.18K
Hightower advisors	-	-	-50.68K
Susquehanna group, llp	-	-	-29.83K
Drw securities	-	-	-25.68K
Citadel advisors	-	-	-20.81K

New Positions

Holder	Shares	% Assets	Change	Value
Vanguard fiduciary trust	8.29K	-	8.29K	$87.26K
Steward partners investment advisory	2.00K	0.00%	2.00K	$21.06K
Caitong asset management	10.00	-	10.00	$105.00

Sold Out

Holder	Change
Jaffetilchin investment partners	-1.00
Fmr	-1.00
Assetmark	-1.00
Allworth financial lp	-2.00
Barclays	-4.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2026	28	21.74%	204,446	61.19%	4	58.24%	14	100.00%	3	-25.00%
Mar 31, 2026	17	-29.17%	108,225	-28.90%	2	19.95%	6	-33.33%	2	-66.67%
Dec 31, 2025	1	-	160	-	-	-	1	-	-	-
Jun 30, 2025	1	-	144	-99.14%	-	205.71%	1	-	-	-100.00%
Mar 31, 2025	1	-95.65%	16,667	-97.94%	-	1.00%	-	-100.00%	1	-83.33%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
DNB Fund Disrpt Opps A EUR Acc	55.16K	1.11%	51.06K
Vanguard Total Stock Mkt Idx Inv	53.07K	1.07%	3.78K
Vanguard Morn Total Stk Mkt Idx Investor	53.07K	1.07%	3.78K
Vanguard MStar Total Stk Mkt Idx Invest	53.07K	1.04%	-
Vanguard Institutional Extnd Mkt Idx Tr	15.38K	0.30%	-
Fidelity Extended Market Index	6.80K	0.14%	203.00
iShares Micro-Cap ETF	6.65K	0.13%	-88.00
Fidelity Series Total Market Index	2.89K	0.06%	1.50K
Vanguard Instl Ttl Stck Mkt Idx Tr	2.12K	0.04%	-
Vanguard Instl Ttl Stck Mkt Index Trust	2.12K	0.04%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jun 04, 2026	Ryan Barbara	-	Sell	$12.80K
Jun 04, 2026	Ryan Barbara	-	Sell	$6.34K
Mar 10, 2026	Ryan Barbara	-	Sell	$4.58K
Mar 10, 2026	Ryan Barbara	-	Sell	$7.78K
Mar 09, 2026	Ryan Barbara	-	Sell	$2.03K

Insider Transactions Trends

Date	Buy	Sell
2026 Q3	-	-
2026 Q2	-	2
2026 Q1	-	6
2025 Q4	-	-
2025 Q3	-	-

INKT Ownership FAQ

Who Owns MiNK Therapeutics?

MiNK Therapeutics shareholders are primarily institutional investors at 4.07%, followed by 59.23% insiders and 36.70% retail investors. The average institutional ownership in MiNK Therapeutics's industry, Biotech Stocks , is 379.61%, which MiNK Therapeutics falls below.

Who owns the most shares of MiNK Therapeutics?

MiNK Therapeutics’s largest shareholders are Geode capital management (17.34K shares, 0.41%), Longbow finance sa (16.67K shares, 0.39%), and Ubs group (15.2K shares, 0.36%). Together, they hold 1.15% of MiNK Therapeutics’s total shares outstanding.

Does Blackrock own MiNK Therapeutics?

Yes, BlackRock owns 0.25% of MiNK Therapeutics, totaling 87.2K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 82.77K$. In the last quarter, BlackRock increased its holdings by 11.05K shares, a 14.51% change.

Who is MiNK Therapeutics’s biggest shareholder by percentage of total assets invested?

Longbow finance sa is MiNK Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.03% of its assets in 16.67K MiNK Therapeutics shares, valued at 175.5K$.

Who is the top mutual fund holder of MiNK Therapeutics shares?

DNB Fund Disrpt Opps A EUR Acc is the top mutual fund holder of MiNK Therapeutics shares, with 1.11% of its total shares outstanding invested in 55.16K MiNK Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools